Jfs Wealth Advisors, LLC Ironwood Pharmaceuticals Inc Transaction History

Jfs Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$5.58 - $8.61 $463 - $714	-83 Reduced 89.25%	10 $0
Q4 2023 Feb 07, 2024	BUY	$8.79 - $11.51 $729 - $955	83 Added 830.0%	93 $1,000
Q3 2023 Nov 02, 2023	SELL	$8.25 - $11.35 $536 - $737	-65 Reduced 86.67%	10 $0
Q1 2023 Apr 19, 2023	SELL	$10.37 - $12.56 $20 - $25	-2 Reduced 2.6%	75 $0
Q4 2022 Feb 13, 2023	BUY	$9.9 - $12.43 $405 - $509	41 Added 113.89%	77 $0
Q3 2022 Oct 21, 2022	SELL	$10.14 - $12.38 $446 - $544	-44 Reduced 55.0%	36 $0
Q2 2022 Aug 02, 2022	BUY	$11.05 - $12.72 $221 - $254	20 Added 33.33%	80 $1,000
Q1 2022 May 02, 2022	BUY	$10.61 - $12.88 $360 - $437	34 Added 130.77%	60 $1,000
Q4 2021 Feb 03, 2022	BUY	$10.86 - $13.95 $282 - $362	26 New	26 $0

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.